Paul Jeng
Stock Analyst at Guggenheim
(0.18)
# 4,729
Out of 5,073 analysts
35
Total ratings
34.5%
Success rate
-21.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paul Jeng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Initiated: Buy | $18 | $14.12 | +27.52% | 1 | Oct 22, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $35 | $8.18 | +327.87% | 1 | Oct 21, 2026 | |
| NBTX Nanobiotix | Reiterated: Buy | $64 | $25.83 | +147.77% | 2 | Sep 25, 2026 | |
| ADAG Adagene | Reiterated: Buy | $10 | $2.41 | +314.94% | 7 | Sep 10, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $54 → $57 | $35.47 | +60.70% | 9 | Sep 9, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | $12 → $10 | $1.02 | +880.39% | 2 | Aug 6, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $45 | $4.29 | +950.18% | 2 | Jun 2, 2026 | |
| IMTX Immatics | Reiterated: Buy | $19 | $7.69 | +147.07% | 5 | May 12, 2026 | |
| CNTX Context Therapeutics | Reiterated: Buy | $5 | $0.2314 | +2,060.76% | 4 | May 6, 2026 | |
| IMCR Immunocore Holdings | Initiated Coverage: Hold | n/a | $32.09 | n/a | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $2.50 | n/a | 1 | Jul 29, 2020 |
ORIC Pharmaceuticals
Oct 22, 2026
Initiated: Buy
Price Target: $18
Current: $14.12
Upside: +27.52%
Kazia Therapeutics
Oct 21, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $8.18
Upside: +327.87%
Nanobiotix
Sep 25, 2026
Reiterated: Buy
Price Target: $64
Current: $25.83
Upside: +147.77%
Adagene
Sep 10, 2026
Reiterated: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
IDEAYA Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $54 → $57
Current: $35.47
Upside: +60.70%
Coherus Oncology
Aug 6, 2026
Reiterated: Buy
Price Target: $12 → $10
Current: $1.02
Upside: +880.39%
Corbus Pharmaceuticals Holdings
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $4.29
Upside: +950.18%
Immatics
May 12, 2026
Reiterated: Buy
Price Target: $19
Current: $7.69
Upside: +147.07%
Context Therapeutics
May 6, 2026
Reiterated: Buy
Price Target: $5
Current: $0.2314
Upside: +2,060.76%
Immunocore Holdings
Sep 17, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $32.09
Upside: n/a
Jul 29, 2020
Initiated Coverage: Buy
Price Target: $50
Current: $2.50
Upside: n/a